标题 |
Telitacicept, a human recombinant fusion protein targeting B lymphocyte stimulator (BlyS) and a proliferationinducing ligand (APRIL), in systemic lupus erythematosus (SLE): Results of a Phase 3 Study
靶向B淋巴细胞刺激因子(BlyS)和增殖诱导配体(APRIL)的人重组融合蛋白替利他西普治疗系统性红斑狼疮(SLE)的3期研究结果
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
作者:Wu D, Li J, Xu D, et al Presented at American College of Rheumatology Convergence 2022; October 18, 2022. |
求助人 | |
下载 |